In-depth blood immune profiling of Good syndrome patients.

Autor: Torres-Valle A; Translational and Clinical Research Program, Centro de investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Aragon L; Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain., Silva SL; Serviço de Imunoalergologia, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal.; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Serrano C; Servicio de Inmunología, Fundación Jiménez Díaz, Madrid, Spain., Marcos M; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Department of Internal Medicine, University Hospital of Salamanca, Salamanca, Spain.; Department of Medicine, University of Salamanca, Salamanca, Spain., Melero J; Servicio de inmunología y genética, Hospital Universitario de Badajoz, Badajoz, Spain., Bonroy C; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Arenas-Caro PP; Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain., Casado DM; Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain., Olaizola PMR; Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain., Neirinck J; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., Hofmans M; Department of Laboratory Medicine, Ghent University Hospital, Ghent, Belgium.; Department of Diagnostic Sciences, Ghent University, Ghent, Belgium., de Arriba S; Pediatrics Department, University Hospital of Salamanca, Salamanca, Spain., Jara M; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; DNA Sequencing Service (NUCLEUS), University of Salamanca, Salamanca, Spain., Prieto C; Bioinformatics service (NUCLEUS), University of Salamanca, Salamanca, Spain., Sousa AE; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Prada Á; Immunology Department, Donostia University Hospital, Osakidetza Basque Health Service, San Sebastián, Spain., van Dongen JJM; Translational and Clinical Research Program, Centro de investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain.; Department of Immunology, Leiden University Medical Center, Leiden, Netherlands., Pérez-Andrés M; Translational and Clinical Research Program, Centro de investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Orfao A; Translational and Clinical Research Program, Centro de investigación del Cáncer (CIC), Instituto de Biología Molecular y Celular del Cáncer (IBMCC), Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca (USAL), Salamanca, Spain.; Cytometry Service, NUCLEUS, Department of Medicine, University of Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2023 Nov 15; Vol. 14, pp. 1285088. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).